Boston Scientific’s $925 Million Acquisition of Preventice Solutions

Latham & Watkins LLP represented Preventice Solutions, Inc. in the transaction. Boston Scientific (NYSE: BSX) entered into a definitive agreement to acquire Preventice Solutions, Inc., a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here